US 11168316
Chimeric clotting factors
granted A61KA61K38/36A61K38/4846
Quick answer
US patent 11168316 (Chimeric clotting factors) held by BIOVERATIV THERAPEUTICS INC. expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/36, A61K38/4846, A61K47/62, A61P